LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients

被引：0
作者：
Block, T.
Zimmermann, F.
Czempiel, H.
机构：
[1] Urol Praxis, Vaterstetten, Germany
[2] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of the 5-year PSA value for predicting prostate cancer recurrence following brachytherapy
    Klein, T. J.
    Stock, R. G.
    Cesaretti, J. A.
    Stone, N. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S176 - S177
  • [32] Evidence that life expectancy is increased in prostate cancer patients treated with low dose-rate (LDR) brachytherapy
    Langley, S.
    Uribe, J.
    Uribe-Lewis, S.
    Deering, C.
    Langley, S.
    Higgins, D.
    Khaksar, S.
    Mehta, S.
    Mikropoulos, C.
    Otter, S.
    Perna, C.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S1398 - S1399
  • [33] ARE THE RISK GROUPS USED FOR EXTERNAL BEAM TREATMENT OF PROSTATE CANCER APPROPRIATE FOR LDR BRACHYTHERAPY?
    Crook, Juanita
    Thames, Howard
    Tang, Chad
    Blanchard, Pierre
    Sanders, Jeremiah
    Ciezki, Jay
    Keyes, Mira
    Morris, Wj
    Merrick, Gregory
    Catton, Charles
    Raziee, Hamid
    Stock, Richard
    Sullivan, Francis J.
    Anscher, Mitch
    Millar, Jeremy
    Frank, Steven
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S35 - S36
  • [34] In-vivo dosimetry using Dosimetry Check: 5-year experience on 345 prostate cancer patients
    Nailon, W. H.
    Welsh, D.
    MacDonald, K.
    Burns, D.
    Forsyth, J.
    Cooke, G.
    Cutanda, F.
    McLaren, D. B.
    Puxeu-Vaque, J.
    Kehoe, T.
    Andiappa, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S777 - S777
  • [35] TESTOSTERONE REPLACEMENT THERAPY IN PATIENTS WITH PROSTATE CANCER AFTER PROSTATECTOMY: A 5-YEAR SINGLE CENTER EXPERIENCE
    Wynia, Blake
    Lee, Ted
    Taneja, Samir
    Lepor, Herbert
    Huang, William
    Stifelman, Michael
    Bjurlin, Marc
    McCullough, Andrew
    Alukal, Joseph
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04) : E527 - E528
  • [36] Low toxicity in LDR brachytherapy boost with real time intraoperative planning in prostate cancer
    Barrado, M.
    Villafranca Iturre, E.
    Sola Galarza, A.
    Fernandez de Manzano, I. Visus
    Navarrete Solano, P.
    Fuentemilla Urio, N.
    Pellejero Pellejero, S.
    Galbete Jimenez, A.
    Rodriguez Mendizabal, M. A.
    Rosas Gutierrez, L. O.
    Barco Gomez, A.
    Martinez Lopez, E. G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1084 - S1085
  • [37] Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer
    Stefan Machtens
    Rolf Baumann
    Jörn Hagemann
    Antje Warszawski
    Andreas Meyer
    Johann H. Karstens
    Udo Jonas
    [J]. World Journal of Urology, 2006, 24 : 289 - 295
  • [38] LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
    Boehle, Andreas
    Zywietz, Dorothea
    Robrahn-Nitschke, Irina
    Lusch, Achim
    Koenig, Inke R.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (11) : 454.e17 - 454.e24
  • [39] Long-term results of interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer
    Machtens, Stefan
    Baumann, Rolf
    Hagemann, Joern
    Warszawski, Antje
    Meyer, Andreas
    Karstens, Johann H.
    Jonas, Udo
    [J]. WORLD JOURNAL OF UROLOGY, 2006, 24 (03) : 289 - 295
  • [40] HIGH-DOSE-RATE (HDR) BRACHYTHERAPY WITH EXTERNAL BEAM RADIOTHERAPY FOR LOCALIZED HIGH RISK PROSTATE CANCER: 5-YEAR RESULTS IN 141 PATIENTS
    Masahito, K.
    Miki, K.
    Aoki, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S382 - S382
12345